As for the FOXP3 stroma/ CD8 tumor expression ratio, patients with high levels also presented worse PFS (23 vs. 37.8 months, p = 0.042) and OS (46.4 vs. 74.3 months, p = 0.025; Figure 3C-3D; Table 2). The gene discussed is FOXP3; the disease is neoplasm.